Now, keep up to date
with daily feeds of newly posted stories
about America's Seniors...click on the box
to the left
Prescription Costs more likely to deter
Hispanics in Study
By Valerie DeBenedette, Contributing Writer
Health Behavior News Service
Drug costs could prevent some people from
filling their prescriptions, which can
interfere with optimal health care.
A
new study of Medicare beneficiaries finds
that cost concerns are more likely keep
Hispanics away from the pharmacy counter
than non-Hispanics.
Researcher used data from a large survey
conducted in 2007 by the Centers for
Medicare & Medicaid Services (CMS), which
resulted in more than 270,000 responses.
The study appears in the May issue of the
Journal of Health Care for the Poor and
Underserved.
More than 20 percent of Hispanics said that
they did not fill a prescription from their
doctor because of the cost of the drug,
compared with a little less than 13 percent
of non-Hispanics.
The discrepancy was not surprising, said
Diane Frankenfield Dr.PH., a senior research
analyst at the CMS in Baltimore.
Since all the respondents were eligible for
prescription coverage through Medicaid Part
D, the study did not evaluate anyone who had
no health insurance, which would presumably
increase the incidence of cost-related
non-adherence.
Although about 15 percent of Americans are
Hispanic, just fewer than 7 percent of
respondents identified themselves as
Hispanic, which is in line with the overall
percentage of Hispanics in Medicare,
Frankenfield said.
The study did not evaluate how the price of
an individual prescription drug affected
cost-related adherence; it only asked if the
price had been a factor in the six months
before the survey.
Other factors can also influence
non-adherence to a prescription regimen,
such as acculturation and language barriers.
Creating an intervention program that works
with cultural issues for Hispanics might
help, Frankenfield said.
“Medication non-adherence is a problem among
the entire U.S. population,” said Rebecca
Snead, executive vice president and chief
executive officer of the National Alliance
of State Pharmacy Associations, in Richmond,
Va.
Health care reforms recently signed into law
might make a difference, Snead said: “If it
is truly cost-related non-adherence and
costs go down, then the new health insurance
rule should help.
"
However, I feel non-adherence is
multifaceted and cost-related non-adherence
is only one of many considerations, although
an important one, for all patients.”
... ..
...
...